This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. GENEVA (AP) — Switzerland’s medical products ...
A new clinical trial led by QIMR Berghofer, in collaboration with University of Sunshine Coast Clinical Trials Network has ...
This October 2024 image provided by Novartis shows GanLum, a new anti-malaria treatment, at a manufacturing facility in Slovenia. (Novartis via AP) NEW YORK (AP) — Researchers on Wednesday reported ...
The Significance of the Discovery Malaria remains one of the most life-threatening diseases globally, particularly in sub-Saharan Africa. According to the World Health Organization (WHO), there were ...
At the turn of the millennium, a new class of drugs derived from ancient Chinese herbal medicine revolutionized malaria care. Artemisinin's, as they're called, are based on extracts from the sweet ...
In a historic move, Swissmedic has approved Coartem Baby, the first malaria treatment specifically for newborns and young ...
Indiana University School of Medicine researchers have identified a way to block the ability of parasites that cause malaria to shield themselves against drug treatments in infected mice--a finding ...
Switzerland's medical products authority has granted the first approval for a malaria medicine designed for small infants, touted as an advance against a disease that takes hundreds of thousands of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results